Released Title Price Sensitive Download Types
2023-01-04 08:19:00 TACTI-003 trial 50% enrolment milestone has been achieved 1 https://app.sharelinktechnologies.com/announcement/asx/668470b9f1cf26f3dc37cbd3954715cc
    Progress Report
2023-01-06 16:13:00 Notification of cessation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/1d99c58a3f496597e6415cea9ed46fed
    Appendix 3H (Notification of cessation of securities)
2023-01-30 08:34:00 Immutep Quarterly Activities Report and Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/0f91b6f79db7898a58f8fb56c5e27494
    Commitments Test Entity - Second Quarter Report
    Commitments Test Entity - Second Quarter Activity Report
2023-02-06 08:48:00 Enrolment Target Reached for INSIGHT-003 Trial in NSCLC 1 https://app.sharelinktechnologies.com/announcement/asx/21bd1a79cad8cf58e978457fd6c2e8a4
    Progress Report
2023-02-24 18:57:00 Half Yearly Report and Accounts 1 https://app.sharelinktechnologies.com/announcement/asx/abb18f77ea7d68ab05254b356fdb17af
    Half Yearly Report
    Half Year Audit Review
    Half Year Directors' Statement
    Half Year Accounts
    Half Year Directors' Report
2023-03-14 08:11:00 Initiation of Ph 2/3 Trial for Metastatic Breast Cancer 1 https://app.sharelinktechnologies.com/announcement/asx/8402efcbece01468b76b0fa4005a14c5
    Progress Report
2023-03-23 11:22:00 Abstract accepted for ESMO's European Lung Cancer Congress 0 https://app.sharelinktechnologies.com/announcement/asx/9dc3e15abdf5451fbbb39a3b8c259f18
    Company Administration - Other
    Web Casts
2023-03-30 09:57:00 Expansion of INSIGHT-003 trial for Efti in 1st Line NSCLC 1 https://app.sharelinktechnologies.com/announcement/asx/403c4a19d46fb25960f615878663d2bd
    Progress Report
2023-03-31 08:15:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/497298999b8a2e5b45dc08f02f90e629
    Change in substantial holding
2023-03-31 17:47:00 Positive Final Data in 2nd Line Metastatic NSCLC Patients 1 https://app.sharelinktechnologies.com/announcement/asx/f988c1e15601a8fa056e52c10ade13d2
    Progress Report
2023-04-11 08:38:00 Immutep Announces Changes to the Board 0 https://app.sharelinktechnologies.com/announcement/asx/46097d2d86ba1badb693265c3bc04cba
    Director Appointment/Resignation
2023-04-11 08:42:00 Appendix 3X - Lis Boyce 0 https://app.sharelinktechnologies.com/announcement/asx/927c8fd20ba87df1e2ac1466ee308755
    Initial Director's Interest Notice
2023-04-11 09:11:00 Appendix 3Z - Lucy Turnbull 0 https://app.sharelinktechnologies.com/announcement/asx/8318651d0edf6157326c8646f909e1b1
    Final Director's Interest Notice
2023-04-11 09:59:00 Notification of cessation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/6e5b72d8925d912a07a823f4ec05d9ce
    Appendix 3H (Notification of cessation of securities)
2023-04-17 08:24:00 Initiation of Phase 2 Trial for Efti in Soft Tissue Sarcoma 1 https://app.sharelinktechnologies.com/announcement/asx/1169ec05c23516d2348ed7a5c455fbd9
    Progress Report
2023-04-18 10:22:00 Response to ASX Aware Query 1 https://app.sharelinktechnologies.com/announcement/asx/1c994fac032e56f004e27e041360aa5a
    Response to ASX Query
2023-04-26 08:46:00 Immutep appoints Dr Florian Vogl as Chief Medical Officer 0 https://app.sharelinktechnologies.com/announcement/asx/09b704e9bd2ace64409e2df725ede205
    Company Administration - Other
2023-04-27 08:02:00 Immutep to announce new TACTI-002 data at ASCO 2023 1 https://app.sharelinktechnologies.com/announcement/asx/5db2283bd902adfc3d57f592caac9c98
    Progress Report
2023-04-27 08:04:00 Immutep Quarterly Activities Report and Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/48a3189ce9758eceaad39da2d354f1a2
    Commitments Test Entity - Third Quarter Report
    Commitments Test Entity - Third Quarter Activity Report
2023-05-01 08:12:00 Approval to start Efti & Bavencio trial in urothelial cancer 1 https://app.sharelinktechnologies.com/announcement/asx/aeed2dc1f96c6bd870149e62922a7742
    Progress Report
2023-05-02 08:18:00 Change of Director's Interest Notice - R Howard 0 https://app.sharelinktechnologies.com/announcement/asx/66f4a35afb4de426f69f05f55c646c04
    Change of Director's Interest Notice
2023-05-16 08:18:00 FDA supportive of Efti registrational trial in lung cancer 1 https://app.sharelinktechnologies.com/announcement/asx/2a7448991abd55a4cd660911fe81de6e
    Progress Report
2023-05-17 09:02:00 Excellent initial Overall Survival Benefit in 1st line NSCLC 1 https://app.sharelinktechnologies.com/announcement/asx/05407d5ff00808c133d3cbd464ba6230
    Progress Report
2023-05-24 09:01:00 Promising New Data in 1st line NSCLC from INSIGHT-003 Trial 1 https://app.sharelinktechnologies.com/announcement/asx/14e57c817bf8a3138d1bfb8defe72c67
    Progress Report
2023-05-25 08:19:00 1st patient dosed in AIPAC-003 ph2/3 breast cancer trial 1 https://app.sharelinktechnologies.com/announcement/asx/e33ba23f3e92b84bb780e4e25a99ff02
    Progress Report
2023-05-26 08:24:00 Publication of Abstracts for ASCO 2023 Annual Meeting 1 https://app.sharelinktechnologies.com/announcement/asx/f0d78fd5e831c528ed67cc7d1cbe2827
    Progress Report - Other
2023-05-29 08:20:00 Charles River Laboratories to run IMP761 Toxicology Study 1 https://app.sharelinktechnologies.com/announcement/asx/7f1929f37eb0b32c87e76e3ef0bdbe70
    Progress Report
2023-05-31 09:21:00 Trading Halt 1 https://app.sharelinktechnologies.com/announcement/asx/055d8400a23745a1a5c5cebf379c5a6c
    Trading Halt
2023-05-31 09:38:00 A$80 million fully underwritten equity raising 1 https://app.sharelinktechnologies.com/announcement/asx/1621e575fb452cff0a043f8abadd02fa
    Placement
    Non-Renounceable Issue
    Issued Capital - Other
2023-05-31 10:10:00 Immutep Capital Raising Presentation 1 https://app.sharelinktechnologies.com/announcement/asx/ed51d503bf41f37d1b9b19cbb0c8fa69
    Company Presentation
2023-05-31 10:25:00 Proposed issue of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/ee1c887f98c0a336a65d4c7e8bd2328b
    Appendix 3B
2023-05-31 10:47:00 Cleansing Notice 0 https://app.sharelinktechnologies.com/announcement/asx/68fa8c1531978aa5eb7069321439442a
    Cleansing Notice
2023-06-01 08:22:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/d6a58fc9a9ee5103744f112d7dd1fa3e
    Change in substantial holding
2023-06-02 09:02:00 Immutep completes institutional pro-rata offer & placement 1 https://app.sharelinktechnologies.com/announcement/asx/0073c0db2a6071e0e66713a3603f7b0d
    Placement
    Non-Renounceable Issue
    Trading Halt Lifted
2023-06-05 08:41:00 Positive final data in 2nd line head and neck cancer at ASCO 0 https://app.sharelinktechnologies.com/announcement/asx/39832be51ce0be052165bb18a77fa66a
    Progress Report
2023-06-06 08:13:00 Immutep retail entitlement offer booklet 0 https://app.sharelinktechnologies.com/announcement/asx/5d26c1365f2a14e7ea7923ef9e5e16f4
    Non-Renounceable Issue
    Disclosure Document
2023-06-06 08:36:00 Immutep letter to ineligible shareholders 0 https://app.sharelinktechnologies.com/announcement/asx/100bb699dfa1f790212e060739275820
    Non-Renounceable Issue
    Letter to Shareholders
2023-06-08 10:20:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/aff1507139a9344a00bfabde4c6e564e
    Appendix 2A (Application for Quotation of Securities
2023-06-08 10:51:00 Cleansing Notice 0 https://app.sharelinktechnologies.com/announcement/asx/9339ba3880470d7aa64531d15aba5a28
    Cleansing Notice
2023-06-09 14:58:00 Becoming a substantial holder 0 https://app.sharelinktechnologies.com/announcement/asx/295c686eddefbe5aafc6281e3ed6ddfb
    Becoming a substantial holder
2023-06-13 08:10:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/13ca429fa75f8b59d856acaf9dc3dbc0
    Change in substantial holding
2023-06-13 18:47:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/68188d4682aa9e7660f9ecab8d73a101
    Change in substantial holding
2023-06-16 16:53:00 Change in substantial holding from IFL 0 https://app.sharelinktechnologies.com/announcement/asx/79bf4f1cd7375951088fbaef7411f7dc
    Change in substantial holding
2023-06-20 14:43:00 Immutep granted US patent for IMP761 agonist LAG-3 antibody 1 https://app.sharelinktechnologies.com/announcement/asx/d9bc116a6c7eb4acf4c158ca37f38629
    Progress Report
2023-06-27 08:16:00 Immutep completes underwritten retail entitlement offer 1 https://app.sharelinktechnologies.com/announcement/asx/513dbcde80c2383fefbd0980415e25cc
    Placement
    Non-Renounceable Issue
2023-06-27 14:37:00 US patent granted for Efti with PD-1 pathway inhibitor 1 https://app.sharelinktechnologies.com/announcement/asx/44c513ba7d296a08c24228e2bba8a6a6
    Progress Report
2023-06-29 10:09:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/93196806a8669d46342f952e63ef2cb9
    Appendix 2A (Application for Quotation of Securities
2023-07-28 08:50:00 1st Patient Dosed in Phase 2 Soft Tissue Sarcoma Trial 1 https://app.sharelinktechnologies.com/announcement/asx/90d484c14aaeb100c5ce46b35263fa02
    Progress Report
2023-07-31 09:07:00 Immutep Quarterly Activities Report and Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/c09b4d888a2da0ed984c8f154fb2ec9e
    Commitments Test Entity - Second Quarter Report
    Commitments Test Entity - Second Quarter Activity Report
2023-07-31 17:16:00 Efti clinical data to be presented at ESMO Congress 2023 0 https://app.sharelinktechnologies.com/announcement/asx/6c3e2f3fa9de7678462e0bd82e50c4e5
    Progress Report
2023-08-01 12:10:00 Immutep receives positive scientific advice from EMA 1 https://app.sharelinktechnologies.com/announcement/asx/c42914b55a383ec9ca0f4d2db19f7f06
    Progress Report
2023-08-18 09:04:00 Immutep Investor Update 0 https://app.sharelinktechnologies.com/announcement/asx/45f3698fcfea504cc15f4072f11c0930
    Periodic Reports - Other
    Letter to Shareholders
2023-08-30 09:38:00 Appendix 4E & 2023 Full Year Statutory Accounts 1 https://app.sharelinktechnologies.com/announcement/asx/80c2aa83e5655589e4f040980ec0e48c
    Annual Report
    Top 20 shareholders
    Preliminary Final Report
    Full Year Accounts
    Full Year Audit Review
    Full Year Directors' Statement
    Full Year Directors' Report
2023-09-06 08:52:00 Immutep to Participate in September Investor Conferences 0 https://app.sharelinktechnologies.com/announcement/asx/860ca7fe9a6416a9f6b90b5514fe6f7d
    Company Administration - Other
2023-09-08 11:08:00 2023 AGM & Key Dates 0 https://app.sharelinktechnologies.com/announcement/asx/e15e6a967f3b05064b805f27fe538895
    Proxy Form
    Notice of Meeting - Other
2023-09-21 08:14:00 Commercial Scale Manufacturing of Efti for Clinical Trials 1 https://app.sharelinktechnologies.com/announcement/asx/57982d4fdccf272dc696b2816eec504c
    Progress Report
2023-09-22 13:17:00 Annual Report to shareholders 0 https://app.sharelinktechnologies.com/announcement/asx/73fada4edfc6546b930b5b2eb64fcaed
    Annual Report
    Top 20 shareholders
    Full Year Accounts
    Full Year Audit Review
    Full Year Directors' Statement
    Full Year Directors' Report
2023-09-22 13:22:00 Appendix 4G and Corporate Governance Statement 0 https://app.sharelinktechnologies.com/announcement/asx/c1a4ff93f99b1476ecfd5f4108f48da2
    Corporate Governance
    Takeover - Appendix 4G
2023-09-22 13:36:00 Notice of Annual General Meeting/Proxy Form 0 https://app.sharelinktechnologies.com/announcement/asx/06b81ca76be8ac5421b6b82b79d09ab9
    Notice of Annual General Meeting
    Proxy Form
    Web Casts
    Letter to Shareholders
2023-10-03 09:12:00 Immutep announces acceptance of abstract for SITC 2023 0 https://app.sharelinktechnologies.com/announcement/asx/d3f2a52daf223fe96208378d2a6a0c3f
    Company Administration - Other
2023-10-03 10:29:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/591d4701a6b797f9941c2279d9637ee4
    Appendix 2A (Application for Quotation of Securities
2023-10-05 13:23:00 Change of Director's Interest Notice - Pete Meyers 0 https://app.sharelinktechnologies.com/announcement/asx/c3aacaee066be1edeed40467be4f6f81
    Change of Director's Interest Notice
2023-10-16 09:10:00 Immutep announces publication of ESMO 2023 abstracts 1 https://app.sharelinktechnologies.com/announcement/asx/3396c0530eb1207c55a3332429e842bf
    Progress Report
2023-10-23 07:48:00 Excellent Overall Survival in Non-Small Cell Lung Cancer 1 https://app.sharelinktechnologies.com/announcement/asx/98607cbd225004836510341598cf973e
    Progress Report
    Web Casts
2023-10-23 07:48:00 Webcast slides for new Efti clinical data in 1st line NSCLC 1 https://app.sharelinktechnologies.com/announcement/asx/a6c7faf314cb1314b2234573cecee4f5
    Company Presentation
2023-10-24 08:12:00 Immutep reports promising data from INSIGHT-003 trial 1 https://app.sharelinktechnologies.com/announcement/asx/3ea234adbf23ba7bd2b7ce7f1e5b9170
    Progress Report
2023-10-24 08:13:00 Immutep AGM 2023 - CEO's Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/d94b7af4d9055e5ef643f740c5345429
    Company Presentation
    Chairman's Address to Shareholders
2023-10-24 08:13:00 Immutep AGM 2023 - Chairman's Address 0 https://app.sharelinktechnologies.com/announcement/asx/f5bdb9365b92dececa7fa6af4c8008bc
    Chairman's Address to Shareholders
2023-10-24 11:52:00 Results of Meeting 0 https://app.sharelinktechnologies.com/announcement/asx/e7879ac7785043e91e297cff0d6de6df
    Results of Meeting
2023-10-25 10:53:00 Immutep receives Australian R&D Tax Incentive 0 https://app.sharelinktechnologies.com/announcement/asx/1710814483ea0dc5c2564f8ecc237e28
    Periodic Reports - Other
    Company Administration - Other
2023-10-25 11:01:00 Annual Report filed on Form 20-F with SEC 0 https://app.sharelinktechnologies.com/announcement/asx/28ad8bc538a1da0f480ce873833e227f
    Annual Report
2023-10-31 08:43:00 Immutep Quarterly Activities Report and Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/cd609b7441de631b08ee6db0e761a13b
    Commitments Test Entity - First Quarter Report
    Commitments Test Entity - First Quarter Activity Report
2023-11-02 08:28:00 Immutep to Participate in November Investor Events 0 https://app.sharelinktechnologies.com/announcement/asx/80e2f3a055fc3edf17ab0f7e49733fae
    Company Administration - Other
2023-11-03 08:16:00 New Biomarker Data from TACTI-002 trial in 1st line NSCLC 1 https://app.sharelinktechnologies.com/announcement/asx/f907c96ffd82ecf194883536e9abe6d4
    Progress Report
2023-11-06 08:29:00 Lead-in phase completed for ph2/3 trial in Breast Cancer 1 https://app.sharelinktechnologies.com/announcement/asx/4098989f68f6f490afb057f9da49026a
    Progress Report
2023-11-09 08:21:00 Immutep Completes Enrolment for TACTI-003 Phase IIb Trial 1 https://app.sharelinktechnologies.com/announcement/asx/576b1c53d52bbcdd3244d3022634a357
    Progress Report
2023-11-22 10:41:00 Proposed issue of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/5d0ccab639ec1f9f443f9ca214216464
    Appendix 3B
2023-11-22 12:31:00 Immutep Announces Site Expansion for INSIGHT-003 Trial 0 https://app.sharelinktechnologies.com/announcement/asx/5443b598e7c1fb41800ce53f0ba4797f
    Progress Report
2023-11-23 09:26:00 Notification regarding unquoted securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/84a125e38b27de392d3977e099651919
    Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2023-11-23 17:24:00 Change of Director's Interest Notice - L Boyce 0 https://app.sharelinktechnologies.com/announcement/asx/189a9f0714ad22cc0d7ab915a88adab7
    Change of Director's Interest Notice
2023-11-23 17:24:00 Change of Director's Interest Notice - R Howard 0 https://app.sharelinktechnologies.com/announcement/asx/0339b3fe5bb74822315b203955281ad4
    Change of Director's Interest Notice
2023-12-07 08:16:00 Immutep receives A$2.6 million French R&D Tax Incentive 1 https://app.sharelinktechnologies.com/announcement/asx/758d74b12957ffc198b17a2cc5bbba34
    Progress Report
    Company Administration - Other
2023-12-21 08:23:00 PEI provides constructive feedback for ph3 lung cancer trial 1 https://app.sharelinktechnologies.com/announcement/asx/0f8347c5dbd5ad072f6341ca8b08bb84
    Progress Report
2023-12-22 15:16:00 Change of Registered Office Address 0 https://app.sharelinktechnologies.com/announcement/asx/879cf786bec259bf890f5a016b873590
    Details of Registered office address
Powered by Share Link